TWD 30.05
(0.0%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 82.55 Million TWD | 11.96% |
2022 | 112.42 Million TWD | -49.24% |
2021 | 221.47 Million TWD | 4.32% |
2020 | 212.29 Million TWD | -5.22% |
2019 | 223.99 Million TWD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 129.34 Million TWD | 56.67% |
2024 Q2 | 129.34 Million TWD | 28.4% |
2023 Q4 | 82.55 Million TWD | 0.0% |
2023 Q3 | 82.55 Million TWD | -28.81% |
2023 Q2 | 115.96 Million TWD | 76.4% |
2023 Q1 | 65.73 Million TWD | -41.52% |
2022 FY | 112.42 Million TWD | -49.24% |
2022 Q4 | 112.42 Million TWD | 0.0% |
2021 FY | 221.47 Million TWD | 4.32% |
2020 FY | 212.29 Million TWD | -5.22% |
2019 FY | 223.99 Million TWD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Bio Preventive Medicine Corp. | 113.44 Million TWD | 27.23% |
Genomics BioSci & Tech. Co.,Ltd. | 283.61 Million TWD | 70.891% |
Advagene Biopharma Co., Ltd. | 870 Thousand TWD | -9389.08% |
Taiwan Bio Therapeutics Co., Ltd | 268.62 Million TWD | 69.267% |
NaviFUS Corp. | 32.69 Million TWD | -152.516% |
G&E Herbal Biotechnology Co., Ltd. | 5.43 Million TWD | -1420.07% |
TaiRx, Inc. | 12.28 Million TWD | -571.944% |
Sinew Pharma Inc. | 6.46 Million TWD | -1177.15% |
Lin BioScience, Inc. | 42.87 Million TWD | -92.557% |
TaiwanJ Pharmaceuticals Co., Ltd. | 1.17 Million TWD | -6949.957% |
Lumosa Therapeutics Co., Ltd. | 12.61 Million TWD | -554.679% |
Anti-Microbial Savior BioteQ Co., Ltd | 1.38 Million TWD | -5869.27% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 402.75 Million TWD | 79.502% |
AP Biosciences Inc | 82.07 Million TWD | -0.58% |
Sunmax Biotechnology Co., Ltd. | 174.08 Million TWD | 52.579% |
RBC Bioscience Corporation | 487.36 Million TWD | 83.061% |
Syngen Biotech Co.,Ltd. | 681.76 Million TWD | 87.891% |
EirGenix Inc. | 465.16 Million TWD | 82.253% |
Enimmune corporation | 45.73 Million TWD | -80.511% |
BRIM Biotechnology, Inc. | 3.59 Million TWD | -2198.302% |
3D Global Biotech Inc. | 10.37 Million TWD | -695.404% |
TaiMed Biologics Inc. | 750.85 Million TWD | 89.005% |
Mycenax Biotech Inc. | 726.27 Million TWD | 88.633% |
TCI GENE Inc. | 6.79 Million TWD | -1114.937% |
SynCore Biotechnology Co.,Ltd | 2.11 Million TWD | -3805.156% |
Oneness Biotech Co., Ltd. | 397.95 Million TWD | 79.255% |
Eusol Biotech Co.,Ltd. | 4.35 Million TWD | -1796.073% |
Feng Chi Biotech Corp. | 10.79 Million TWD | -664.54% |
NeoCore Technology Co., Ltd. | 96.89 Million TWD | 14.796% |
TWi Biotechnology, Inc. | 7.97 Million TWD | -935.692% |
Neith Corporation | 3.54 Million TWD | -2231.404% |
Sunny Pharmtech Inc. | 391.42 Million TWD | 78.909% |
VBI | - TWD | -Infinity% |
Ever Supreme Bio Technology Co., Ltd | 5.89 Million TWD | -1299.712% |
GeneReach Biotechnology Corp. | 257.03 Million TWD | 67.882% |
Shine-On BioMedical Co.,Ltd. | 538 Thousand TWD | -15244.796% |
CHO Pharma, Inc. | - TWD | -Infinity% |
Andros Pharmaceuticals Co.,Ltd | 27.12 Million TWD | -204.395% |
MegaPro Biomedical Co., Ltd | 8.31 Million TWD | -892.486% |
Visgeneer Inc. | 158.6 Million TWD | 47.95% |
Greenyn Biotechnology Co., Ltd | 196.13 Million TWD | 57.909% |
BioLASCO Taiwan Co., Ltd. | 58.2 Million TWD | -41.832% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 417.01 Million TWD | 80.203% |
Sagittarius Life Science Corp | 13.32 Million TWD | -519.643% |
BioGend Therapeutics Co., Ltd. | 13.09 Million TWD | -530.576% |
GlycoNex Incorporation | 900 Thousand TWD | -9072.778% |
Medigen Biotechnology Corp. | 2.91 Billion TWD | 97.165% |
Pharmosa Biopharm Inc. | 144.36 Million TWD | 42.817% |
PharmaEngine, Inc. | 14.8 Million TWD | -457.465% |
Intech Biopharm Corporation | 1.43 Billion TWD | 94.247% |
Taiwan Advance Bio-Pharmaceutical Inc. | 320.13 Million TWD | 74.212% |
BiOptic Inc. | 93.19 Million TWD | 11.42% |
TaiGen Biopharmaceuticals Holdings Limited | 74.68 Million TWD | -10.535% |
Senhwa Biosciences, Inc. | 9.6 Million TWD | -759.858% |
NatureWise Biotech & Medicals Corporation | 10.68 Million TWD | -672.842% |
OBI Pharma, Inc. | 501.05 Million TWD | 83.524% |
Savior Lifetec Corporation | 270.37 Million TWD | 69.467% |
Great Novel Therapeutics Biotech & Medicals | 14.37 Million TWD | -474.296% |
Level Biotechnology Inc. | 13.5 Million TWD | -511.428% |
Medigen Vaccine Biologics Corporation | 1.97 Billion TWD | 95.819% |
Meribank Biotech Co., Ltd | 34.03 Million TWD | -142.531% |
Acepodia, Inc. | 273.81 Million TWD | 69.85% |
Caliway Biopharmaceuticals Co., Ltd. | 20.45 Million TWD | -303.534% |